Ivani Brys Selected Research

3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methyl- 6- methylaminopyridin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanone

1/2018

Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT1A receptor biased agonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivani Brys Research Topics

Disease

6	Parkinson Disease (Parkinson's Disease) 05/2022 - 03/2016
3	Dyskinesias (Dyskinesia) 05/2022 - 03/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Cognitive Dysfunction 01/2022
1	Parkinsonian Disorders (Parkinsonism) 03/2016
1	Fetal Alcohol Spectrum Disorders 11/2014

Drug/Important Bio-Agent (IBA)

3	Levodopa (L Dopa)FDA LinkGeneric 05/2022 - 03/2016
2	Dopamine (Intropin)FDA LinkGeneric 05/2022 - 01/2018
2	alpha-SynucleinIBA 08/2017 - 01/2017
1	3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methyl- 6- methylaminopyridin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA 01/2018
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2018
1	3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA 01/2018
1	befiradolIBA 01/2018
1	Pharmaceutical PreparationsIBA 03/2016
1	Ethanol (Ethyl Alcohol)IBA 11/2014

Therapy/Procedure

3	Therapeutics 05/2022 - 01/2018
1	Transcranial Direct Current Stimulation 01/2022
1	Spinal Cord Stimulation 01/2017